Work

Phase I/II randomized trial of GM.CD40L vaccine plus/minus CCL21 in advanced lung adenocarcinoma: Final results.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.9037

Authors: Jhanelle Elaine Gray, Alberto Chiappori, Charles C. Williams, Tawee Tanvetyanon, Eric B. Haura, Ben C. Creelan, Rebecca D. Devane, Renee Smilee, David Noyes, Jongphil Kim, Scott Joseph Antonia

Institution: Moffitt Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889913602

Cites:

Cited by: 4

Related to: 10